Showing results (101-110 of 123) with videos related to

Sort By:
Pageof 13
American Journal of Surgery|April 17, 2022
Does race affect the long-term survival benefit of systemic therapy in pancreatic adenocarcinoma?Ahmer Irfan, Hua A Fang, Seifeldin Awad, et al.
Surgery|July 25, 2009
Triptolide therapy for neuroblastoma decreases cell viability in vitro and inhibits tumor growth in vivoMara B Antonoff, Rohit Chugh, Daniel Borja-Cacho, et al.
Theranostics|July 9, 2019
O-GlcNAc modification of Sox2 regulates self-renewal in pancreatic cancer by promoting its stabilityNikita S Sharma, Vineet K Gupta, Patricia Dauer, et al.
Science Translational Medicine|October 19, 2012
A preclinical evaluation of Minnelide as a therapeutic agent against pancreatic cancerRohit Chugh, Veena Sangwan, Satish P Patil, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|June 17, 2020
An Immunocompetent Model of Pancreatic Cancer Resection and RecurrenceBhuwan Giri, Anthony Ferrantella, Prateek Sharma, et al.
Cancers|June 2, 2021
Modulation of Early Neutrophil Granulation: The Circulating Tumor Cell-Extravesicular Connection in Pancreatic Ductal AdenocarcinomaHarrys Kishore Charles Jacob, John Lalith Charles Richard, Rossana Signorelli, et al.
Journal of the American College of Surgeons|February 21, 2017
Systemic Chemotherapy Combined with Resection for Locally Advanced Gallbladder Carcinoma: Surgical and Survival OutcomesJohn M Creasy, Debra A Goldman, Vikas Dudeja, et al.
Gastroenterology|August 14, 2016
Release of Cathepsin B in Cytosol Causes Cell Death in Acute PancreatitisRupjyoti Talukdar, Archana Sareen, Hongyan Zhu, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|May 10, 2017
Predicting Residual Disease in Incidental Gallbladder Cancer: Risk Stratification for Modified Treatment StrategiesJohn M Creasy, Debra A Goldman, Mithat Gonen, et al.
Pageof 13